FDA Rheumatology Drug Approvals: Pediatric lupus, spondyloarthritis and more

From a new biosimilar to a first-ever approved drug to treat pediatric lupus patients, the Food & Drug Administration has approved several new medications in recent months. In this slideshow, we offer a brief overview of these new therapeutics.